Advertisement
Novara — A Smarter Way to Access Global Markets
LIVE DESK·Global markets desk

Latest

ISS Backs Two ATG Capital Nominees for Empery Digital Board
EquitiesArticle

ISS Backs Two ATG Capital Nominees for Empery Digital Board

Proxy advisory firm recommends shareholder support for ATG's board slate and withhold votes from two incumbent directors at Empery Digital's Oct. 14 annual meeting.

Priya Anand · 25 Sept 2026
Moleculin Biotech Presents Preclinical Pancreatic Cancer Data at AACR
EquitiesArticle

Moleculin Biotech Presents Preclinical Pancreatic Cancer Data at AACR

The company shared preclinical findings on its Annamycin candidate showing immune-mediated antitumor activity in pancreatic cancer, while its primary clinical program targets relapsed AML.

Priya Anand · 25 Sept 2026
EU holiday package prices rise 3.2% in August, airfares slip 0.4%
InflationArticle

EU holiday package prices rise 3.2% in August, airfares slip 0.4%

Eurostat data show EU package holiday costs matched the bloc's 3.2% inflation rate in August 2026, while passenger air transport prices fell 0.4% year‑on‑year.

Elena Kovač · 25 Sept 2026
Hungary may cut rates this year if euro plan progresses, deputy governor says
Central BanksArticle

Hungary may cut rates this year if euro plan progresses, deputy governor says

The National Bank of Hungary left its rate steady at 5.5% and cut its inflation target to 2.5%. Deputy Governor Zoltan Kurali said another easing remains possible by year-end if fiscal clarity arrives and euro adoption advances.

Elena Kovač · 25 Sept 2026
Turnium Technology raises up to C$3.5m via private placement, settles debt
EquitiesArticle

Turnium Technology raises up to C$3.5m via private placement, settles debt

Vancouver-based Turnium Technology plans a C$3.5 million non-brokered private placement and a C$2 million debt settlement under NI 45-106.

Priya Anand · 25 Sept 2026
Island, Cyera Lead $800M Week of Cybersecurity Funding
StartupsArticle

Island, Cyera Lead $800M Week of Cybersecurity Funding

Two cybersecurity firms each raised $400 million in the largest U.S. startup funding rounds of the week, topping a list that also included significant bets on AI and biotech.

Lucas Ferreira · 25 Sept 2026
Bristol Myers' Zenbexus shows higher response rates in myeloma trial
CompaniesArticle

Bristol Myers' Zenbexus shows higher response rates in myeloma trial

Phase 3 EXCALIBER‑RRMM data presented in Glasgow show Zenbexus plus daratumumab and dexamethasone more than doubled MRD‑negative complete responses versus the standard regimen.

Helena Vásquez · 25 Sept 2026
Bitget revises security breach loss to $388 million after more complete accounting
CryptoArticle

Bitget revises security breach loss to $388 million after more complete accounting

Crypto exchange Bitget updated its incident report Friday, raising the stolen asset figure to $387.5 million and confirming the breach remains contained.

Marcus Webb · 25 Sept 2026
AllianceBernstein Names Onur Erzan as New CEO, Effective April 2027
EquitiesArticle

AllianceBernstein Names Onur Erzan as New CEO, Effective April 2027

Equitable Holdings selects former McKinsey executive to lead $919 billion asset manager as Bernstein steps down after a decade.

Priya Anand · 25 Sept 2026
Accsys shareholders approve all 15 AGM resolutions, appoint Deloitte as auditor
EarningsArticle

Accsys shareholders approve all 15 AGM resolutions, appoint Deloitte as auditor

Accsys Technologies PLC shareholders backed every proposal at its annual meeting, including a switch from PwC to Deloitte and new share issuance authorities.

Priya Anand · 25 Sept 2026
OneMedNet Announces 1-for-10 Reverse Stock Split for Nasdaq Listing Compliance
EquitiesArticle

OneMedNet Announces 1-for-10 Reverse Stock Split for Nasdaq Listing Compliance

The company will reduce outstanding shares to meet Nasdaq’s minimum bid price requirement, effective September 29, 2026.

Priya Anand · 25 Sept 2026
Newron Halts US Recruitment for Evenamide Phase-3 Study Amid FDA Pause
EquitiesArticle

Newron Halts US Recruitment for Evenamide Phase-3 Study Amid FDA Pause

Swiss biopharma firm pauses US patient enrollment in schizophrenia trial after FDA confirms temporary hold following a participant’s death outside the U.S., while expanding global recruitment for the drug’s development.

Priya Anand · 25 Sept 2026
FedWatch tool shows 56% chance of September 2026 rate hike
Central BanksArticle

FedWatch tool shows 56% chance of September 2026 rate hike

Market pricing shifts after Fed Chair Warsh’s Jackson Hole speech raise odds of a 25-basis-point hike to nearly 56% at the September 16 FOMC meeting.

Elena Kovač · 25 Sept 2026
European equities end week with modest gains
EquitiesArticle

European equities end week with modest gains

EuroStoxx 50 closes at 6,302.82, up 0.48%, while Swiss SMI and UK FTSE 100 also rise. Analysts warn of persistent inflation and rising interest rates.

Priya Anand · 25 Sept 2026
Strategy seeks shareholder vote to shift preferred stock dividends to daily schedule
EquitiesArticle

Strategy seeks shareholder vote to shift preferred stock dividends to daily schedule

Strategy plans to move its four preferred shares to daily dividend payments, pending a virtual special meeting on Oct. 28, with the first daily payout slated for Nov. 2.

Priya Anand · 25 Sept 2026
CQS New City High Yield Fund raises 2M shares via blocklisting at 50.6p
EquitiesArticle

CQS New City High Yield Fund raises 2M shares via blocklisting at 50.6p

The fund will use proceeds from the issuance to cover its blocklisting facility, with total voting rights unchanged at 727.6M shares.

Priya Anand · 25 Sept 2026
Bernstein Downgrades Deutsche Telekom on T-Mobile US Risks; BT Named Top European Telecom Pick
M&AArticle

Bernstein Downgrades Deutsche Telekom on T-Mobile US Risks; BT Named Top European Telecom Pick

Analysts cut Deutsche Telekom’s valuation amid uncertainty over a potential U.S. merger and German broadband competition, while BT’s outlook improves with Openreach stabilization and reduced capital expenditure.

Lucas Ferreira · 25 Sept 2026
DNP Select Income Fund hits 52-week low at $9.68
EquitiesArticle

DNP Select Income Fund hits 52-week low at $9.68

Fund’s valuation drops amid market pressures, despite 40-year dividend streak and stable returns.

Priya Anand · 25 Sept 2026
OpenText reduces tender offer for 2028 senior notes to $300M
EquitiesArticle

OpenText reduces tender offer for 2028 senior notes to $300M

OpenText Corporation amends its tender offer for outstanding 3.875% Senior Notes due 2028, reducing the aggregate maximum tender amount to $300 million from $450 million.

Priya Anand · 25 Sept 2026
Sasol Non-Executive Director Rhidwaan Gasant Resigns
EquitiesArticle

Sasol Non-Executive Director Rhidwaan Gasant Resigns

Rhidwaan Gasant steps down from Sasol Limited's board for personal reasons, effective September 25, 2026. The move aligns with the company's succession plan.

Priya Anand · 25 Sept 2026
Nauticus Robotics seeks up to $50M strategic investment
StartupsArticle

Nauticus Robotics seeks up to $50M strategic investment

Houston-based Nauticus Robotics outlines a non-binding letter of intent for a potential equity investment to advance autonomous ocean robotics.

Lucas Ferreira · 25 Sept 2026
Crypto and TradFi Clash Over Tokenized Assets, Payments
CompaniesArticle

Crypto and TradFi Clash Over Tokenized Assets, Payments

Binance invests $100M in Circle, Canada’s big banks test tokenized deposits, and the NYSE partners with Blockchain.com — all signals of a turf war between crypto firms and traditional finance.

Helena Vásquez · 25 Sept 2026
Huntington Ingalls Shares Fall to 52‑Week Low of $263.44 Amid Mixed Q2 Results
EquitiesArticle

Huntington Ingalls Shares Fall to 52‑Week Low of $263.44 Amid Mixed Q2 Results

The defense contractor’s stock slipped to its lowest level in a year after reporting second‑quarter earnings that beat estimates, while analysts issued mixed price‑target revisions and the firm secured a $336 million carrier contract.

Priya Anand · 25 Sept 2026
Philogen H1 2026 cash tops EUR 300 million as pipeline advances
EarningsArticle

Philogen H1 2026 cash tops EUR 300 million as pipeline advances

Philogen SpA reported cash reserves exceeding EUR 300 million in H1 2026, up from EUR 100 million in H1 2025 and EUR 64 million in H1 2024. The company also reported an EBITDA loss of EUR 20 million for the period.

Priya Anand · 25 Sept 2026
← NewerPage 16 of 892Older →